Navigation Links
Cancer Advances Acquires the Intellectual Property for a Suite of Products that Enhance the Immune System in Treatment of Gastric, Pancreatic, and Colorectal Cancers
Date:2/2/2009

DURHAM, N.C., Feb. 2 /PRNewswire/ -- Cancer Advances, Inc. (Cancer Advances), a Cato BioVentures portfolio company, announced today that it has completed its acquisition of all the technology and intellectual property for a suite of products that enhance the immune system for application in three gastrointestinal cancers. Cancer Advances was created as a wholly owned subsidiary of Cato BioVentures to acquire products developed to inhibit the hormone, gastrin, for an undisclosed purchase price. This broad intellectual property portfolio includes composition and use-protection for a lead compound, Polyclonal Antibody Stimulator (PAS), that has been clinically studied in gastric, pancreatic, and colorectal cancers. Cato Research Ltd. (Cato Research) will be responsible for Cancer Advances' strategic drug development and regulatory activities.

"We are excited about continuing the development of PAS in pancreatic and gastric cancers," said Lynda Sutton, COO of Cato Research and President of Cancer Advances. "The flexible, broad-based strategic relationship between Cancer Advances, Cato BioVentures, and Cato Research position us well to execute our innovative drug development model where we are able to fully leverage our contract research and development resources while remaining capital efficient."

The purchase agreement includes multiple patents as well as clinical and safety data for the more than 1,100 patients who have been treated with PAS to date for gastric, pancreatic, and colorectal cancers. Cancer Advances will be seeking additional funding for the company as well as potential development partners.

About PAS

PAS is an active immunotherapeutic that induces antibodies against the hormone, gastrin 17 (G17), and its precursor, (gly)G17, of which there is extensive published evidence for a central role of both of these endogenous compounds in the development and progression of gastrointestinal
'/>"/>

SOURCE Cancer Advances, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Pioneering Cancer Center Introduces Advanced Varian RapidArc(TM) Treatments for Cancer Patients in Central Germany
2. Amgens Breakaway from Cancer Initiative Expands to Help Cancer Patients Access Broad Spectrum of Cancer Resources and Services
3. REXIN-G Shrinks Metastatic Tumors and Triples Survival Time in Chemotherapy-Resistant Pancreatic Cancer: Analysis of a U.S. Phase I/II Clinical Trial (Proceedings of ASCO GI Symposium 2009)
4. Introducing deCODEme Cardio(TM) and deCODEme Cancer(TM)
5. Rosetta Genomics and Collaborators Unveil Colon Cancer Screening Diagnostic; Identified Candidate MicroRNA Biomarkers in Serum
6. National Cancer Institute: Battling Cancer and a Recession
7. Poniard Pharmaceuticals Announces Positive Tumor Response and Neuropathy Data from Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer
8. Trinitas Comprehensive Cancer Center Now Offering Cancer Patients Faster, Ultra-Precise Radiation Using New RapidArc Technology
9. First Patient Dosed in Phase 2 Clinical Trial of NKTR-102 in Ovarian Cancer
10. Data Published in Nature Cell Biology Reveal Novel Function of Drug Target EpCAM in Cancer Cell Signalling
11. Genomic Health Announces Commencement of QUASAR Clinical Validation Study for Oncotype DX(R) Colon Cancer Assay

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., , COPENHAGEN, Dec. 2 T...e with BioIsoprene technology, a breakthrough alte...edient in the manufacture of synthetic rubber with..., Denmark, this week. One tire will be on display ...penhagen International Airport throughout December...
(Date:12/2/2009)..., , LIBREVILLE, Gabon, December 2 /P...y in Africa: Everyone,s Problem and Heritage" ,...iodiversity, 2-3 June 2010 the,Gabonese Republic i...e,(Gabon) on the issue of safeguarding biological ...ed by government and state leaders, ministers,sci...
(Date:12/2/2009)..., , JERUSALEM, Israel, Decembe...feasibility study evaluating the preclinical (anim...oduct which combines technology from Weill,Cornell...have potential to,treat inherited anemias such as ...ing a series of technologies to expand, ex vivo,p...
(Date:12/2/2009)..., , NANJING, China, Dec. 2 /PRNews...re" or the "Company") (NYSE: SCR ), a leading ph...nt, manufacturing, and marketing of branded,generi...announced that 105 of,its drugs have been included...L"), which was issued by China,s Ministry of Human...
Breaking Biology Technology:The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3Libreville International Conference 2-3 June 2010 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3
... Madison, Wis. - For his work in micro technology...ll receive the first Pioneers of Miniaturization ...ison Department of Biomedical Engineering, will r...ence on Miniaturized Systems for Chemistry and the... Lab on a Chip Journal and Corning, Inc. , ,Bee...
... Editor,s note: This is the fourth in a series of ...echnology or biotechnology sectors. , , Madison...ed we would be moving on to forming the entity. I...bout the last column that bears addressing. As a ...6, discussed naming the entity. , ,These columns ...
... Madison, Wis. - Sonic Foundry, Inc. has closed...on stock in which it raised $11.25 million for gen...on Dec. 21 the offering of common stock at $3.75 p...owing a shelf-registration statement previously fi... , ,Sonic Foundry, which develops a rich-media pro...
Other Biology Technology:Early Stage, Step 4: Cautionary trademark tales 2Early Stage, Step 4: Cautionary trademark tales 3
(Date:12/2/2009)... NY, December 2, 2009 Commonly prescribed beta 2 ...ma in pregnant women as well as pre-term labor may...rs, psychiatric pathology, cognitive problems and ...ng to a new study published in the December 2009 i...cology . , Beta 2 adrenergic agonist drugs as a ...
(Date:12/1/2009)...peaking, ants have two different feeding strategie...rous," meaning that they are generalist predators ...eir remains. Some, however, are "herbivorous". T...r, the bulk of their diets consist of plant-derive...s produced by plants to attract ants, called extra...
(Date:12/1/2009)...rly in Alzheimer,s disease, nerve cell degeneratio...utic options may possibly be derived from steering...findings have been published in the current issue ...il only a few years ago, neurogenesis the process...mpossible in the adult brain. The textbooks assert...
Breaking Biology News(10 mins):Treatments for asthma and pre-term labor may increase risk of autism in developing fetus 2Bacterial gut symbionts are tightly linked with the evolution of herbivory in ants 2New source discovered for the generation of nerve cells in the brain 2Cinergy Health Commentary on Americas Prescription Addiction 50331 1Cinergy Health Commentary on Americas Prescription Addiction 50331 2GIE 3A Gastrointestinal Endoscopy June issue study highlights 50327 1GIE 3A Gastrointestinal Endoscopy June issue study highlights 50327 2GIE 3A Gastrointestinal Endoscopy June issue study highlights 50327 3GIE 3A Gastrointestinal Endoscopy June issue study highlights 50327 4GIE 3A Gastrointestinal Endoscopy June issue study highlights 50327 547 000 Elderly Hurt in Walker Cane Mishaps Each Year 50323 147 000 Elderly Hurt in Walker Cane Mishaps Each Year 50323 2
...earchers for many years has been explained by UK s...maintaining the balance of carbon in the Earth,s a... it has been a mystery to scientists why some type...researchers at the Universities of Cambridge and K...dependent but beneficial relationship with bacteri...
... that they can,t wriggle off in opposite direction...opean Molecular Biology Laboratory (EMBL) and coll...iscovered that something similar happens to a prot...sue. Their work appears in the current issue of th...ooks like millions of tiny pistons, stacked end-to...
...wn as ,tandem running, to lead another ant from th...nts control both the speed and course of the run. ...n of ,formal, teaching has been recognised in any ...it could be the value of information, rather than ...the evolution of teaching. , The research, by Pr...
Other Biology News:The secret life of algae 2The giant protein titin helps build muscles 2First demonstration of 'teaching' in non-human animals 2
Rabbit Anti-Human POU2F2 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Rabbit Anti-IKKbeta / IKK-2 Polyclonal Antibody, Unconjugated from BioVision
FailSafe PCR 2X PreMix E from EPICENTRE Biotechnologies
EGY48 from Invitrogen
Biology Products: